US appeals court supports Amgen in NFkappaB dispute with Ariad
04 June 2009
Nancy Faigen
The US Court of Appeals for the Federal Circuit has upheld a lower court's summary judgment opinion, which concluded that
Amgen and
Wyeth's arthritis treatment Enbrel (etanercept), a TNF-blocker, does not infringe
Ariad's US NFkappaB patent.
The Delaware district court last year granted Amgen's...
Please Login to read the full article.
04 June 2009
Nancy Faigen
The Delaware district court last year granted Amgen's...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Supreme Court upholds 'clear and convincing' patent standard, rules against Microsoft
- Metaphors of rocks and baseball bats dominate arguments in Myriad patent case
- US appeals court reverses $1.67 BN decision against Abbott in Humira patent case
- US judgement in anti-CD20 Mab suit favours GSK's Arzerra: Genentech/Biogen to appeal
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
